San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium


Press Release

December 04, 2021
1 min read

Breast cancer researchers to be honored at symposium


Press Release

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Representatives of San Antonio Breast Cancer Symposium and American Association for Cancer Research will honor two individuals for their significant contributions to breast cancer research.

Helen M. Piwnica-Worms, PhD, will receive the AACR Distinguished Lectureship in Breast Cancer Research.

Fabrice André, MD, PhD, will receive the AACR Outstanding Investigator Award for Breast Cancer Research.

“This year’s recipients of the two AACR awards to be given at SABCS have greatly contributed to our understanding of mechanisms of breast cancer progression, translational research, clinical trials and new drug approvals,” Carlos L. Arteaga, MD, FAACR, past president of AACR and director of UT Southwestern Harold C. Simmons Comprehensive Cancer Center, said in a press release. “Their findings have helped to inform new insights for the prevention and treatment of breast cancer that hold great promise for patients.”

Helen Piwnica-Worms, PhD
Helen M. Piwnica-Worms

Piwnica-Worms is Senator A.M. Aikin Jr. distinguished chair and professor of experimental radiation oncology at The University of Texas MD Anderson Cancer Center. She will be recognized for her contributions to understanding how the cell cycle is regulated and how alterations in cell cycle control mechanisms contribute to human cancer.

Piwnica-Worms’ lecture will be titled “Translation of fundamental cell cycle principles to targeted cancer therapies.”

Fabrice Andre, MD, PhD
Fabrice André

André is director of research and a consultant medical oncologist at Gustave Roussy in Villejuif, France, and a professor of medicine at Paris-Saclay University. He will be recognized for his work in translational and clinical breast cancer research, including his contributions to leading several high-impact clinical trials.

André’s lecture will be titled “Moving toward precision medicine for patients with breast cancer.”